Cost Analysis of Erlotinib Versus Chemotherapy for First-Line Treatment of Non–small-Cell Lung Cancer in Frail Elderly Patients Participating in a Prospective Phase 2 Study (GFPC 0505)

[pdf]Clin Lung Cancer 2012[/pdf]